Michael Strader
@mstrader.bsky.social
Canadian/Irish Nephrologist in training - ☘️🇮🇪🇨🇦
The future is precise and found in liquid gold.
The Path to Precision in Acute Kidney Injury doi.org/10.62716/kn....
The Path to Precision in Acute Kidney Injury doi.org/10.62716/kn....
The Path to Precision in Acute Kidney Injury
"The Path to Precision in Acute Kidney Injury" published on 06 Jun 2025 by American Society of Nephrology.
doi.org
June 11, 2025 at 3:35 PM
The future is precise and found in liquid gold.
The Path to Precision in Acute Kidney Injury doi.org/10.62716/kn....
The Path to Precision in Acute Kidney Injury doi.org/10.62716/kn....
Reposted by Michael Strader
April 24, 2025 at 8:31 AM
Reposted by Michael Strader
Prospective Study of a #PointOfCare #Diagnostic Test for Acute Kidney Injury #AKI in a South Asian Hospital
#VisualAbstract by @krishnadoctor1
www.kireports.org/ar...
#VisualAbstract by @krishnadoctor1
www.kireports.org/ar...
April 23, 2025 at 3:00 PM
Prospective Study of a #PointOfCare #Diagnostic Test for Acute Kidney Injury #AKI in a South Asian Hospital
#VisualAbstract by @krishnadoctor1
www.kireports.org/ar...
#VisualAbstract by @krishnadoctor1
www.kireports.org/ar...
Reposted by Michael Strader
Our March issue is live! Our editorial highlights Ireland’s outlier status in European primary health care. It is the only EU country without universal primary care, leaving 58% of residents without free access. It’s time for Ireland to align with European standards www.thelancet.com/journals/lan...
March 3, 2025 at 4:13 PM
Our March issue is live! Our editorial highlights Ireland’s outlier status in European primary health care. It is the only EU country without universal primary care, leaving 58% of residents without free access. It’s time for Ireland to align with European standards www.thelancet.com/journals/lan...
Excited to show the sub-clinical AKI we are missing with Cr and the benefit of novel BMs (FDA approved panel for nephrotoxicity) - Kidney International Reports www.kireports.org/article/S246...
Early and Sensitive Detection of Cisplatin-Induced Kidney Injury Using Novel Biomarkers
We evaluated a panel of novel urinary and serum biomarkers (BMs) for early and sensitive
detection of cisplatin drug-induced kidney injury (DIKI) in patients with cancer,
comparing their diagnostic ac...
www.kireports.org
March 3, 2025 at 8:00 PM
Excited to show the sub-clinical AKI we are missing with Cr and the benefit of novel BMs (FDA approved panel for nephrotoxicity) - Kidney International Reports www.kireports.org/article/S246...